Skip to main content
The Journal of Clinical and Aesthetic Dermatology logoLink to The Journal of Clinical and Aesthetic Dermatology
. 2021 Apr 1;14(4):38–40.

A Series of Tattoo-associated Mycobacterium Fortuitum Infections

Todd E Schlesinger 1,2,3,4,, Ashley E Wilson 1,2,3,4, Lisa Trivedi 1,2,3,4, Phillip J Latham 1,2,3,4, Robert Ball 1,2,3,4
PMCID: PMC8142829  PMID: 34055187

Abstract

Mycobacterium fortuitum is a rapidly growing mycobacterium known to spread through many sources, including tap water. This organism can have variable presentation between patients which can lead to a delay in diagnosis. Here, we report a series of eight cases of tattoo-associated M. fortuitum infections that presented between December 2010 and January 2011, which were later linked to a single tattoo provider using gray tattoo ink made by diluting black ink with nonsterile tap water. In this case series, we emphasize the lack of pathognomonic features of these infections, the variability in culture and biopsy results, the importance of obtaining a culture in addition to a biopsy, and the importance of identifying the source of infection when determining management.

Keywords: Mycobacterium fortuitum, tattoo-associated infection, tap water, granulomatous dermatitis, acid-fast bacilli, culture, tattooing, granuloma, outbreak


Approximately 50 different mycobacterial species can cause disease in humans and several of them fall into the category of nontuberculous mycobacterium (NTM).1 Mycobacterium fortuitum, Mycobacterium chelonae, and Mycobacterium abscessus can be further categorized as rapidly growing mycobacteria (RGMs).3 This category of mycobacterium can be found in a variety of locations, such as surface water, tap water, soil, domestic and wild animals, milk, and food products.25 They have also been known to cause infections of surgical sites after exposure to nonsterile tap water.6 The distinct clinical symptoms include pulmonary disease, lymphadenitis, disseminated disease, and skin and soft tissue infections. However, they can also inhabit body surfaces or secretions without causing disease, making them difficult to diagnose in a clinical setting.7

Specifically, M. fortuitum infects by direct inoculation of skin and soft tissue and typically results in presentation as a single lesion.8 Mycobacterium share the common description of acid-fast bacilli, so further testing is required to differentiate the different organisms.7 Biopsy and culture followed by polymerase chain reaction (PCR) and nucleic acid-specific tests are used to determine the presence and type of RGM, but treatment can vary among the specific types.9 M. fortuitum can show resistance to certain macrolide antibiotics via the erm resistance gene, and the optimal drugs for treatment include amikacin, ciprofloxacin, levofloxacin, moxifloxacin, sulfonamides and imipenem.10

We report an eight-patient series of M. fortuitum infections in the Charleston, South Carolina area. The infections were associated with a single tattoo-administering establishment. Each patient was unique in terms of presentation and laboratory results, but the commonality of an M. fortuitum infection was concluded.

CASE PRESENTATIONS

Index case. On February 11, 2011, a 41-year-old Caucasian male received a tattoo on his right forearm containing red; yellow; and, applied last, gray inks. Three days after receiving the black ink, he experienced redness, swelling, painful bleeding, small pustules and scabs primarily in the areas tattooed with black-appearing ink (Figure 1A). After two months of persistent symptoms, he presented to the emergency department on March 7, 2011, and received anti-inflammatories, oral antibiotics, and topical therapy. These treatments provided temporary relief of symptoms; however, subsequent worsening occurred. On March 11, 2011, he returned to the emergency department due to lack of improvement and he was subsequently admitted and received intravenous clindamycin, topical clobetasol ointment, and a 12-day prednisone taper. He was discharged with instructions to continue oral antibiotics, prednisone, and topical clobetasol ointment. He followed up with his private-practice dermatologist, where he underwent a biopsy (Figure 1B) and tissue culture. An acid-fast stain was positive (Figure 1C), and the presence of a mycobacterium was confirmed by tissue culture (Figure 1D). Following the identification of M. fortuitum, he was treated with ciprofloxacin and linezolid for at least 3 to 4 months.

FIGURE 1.

FIGURE 1.

A) Clinical appearance demonstrating nodular and edematous plaques with overlying scale and pustules confined to the areas of gray tattoo ink; B) Hematoxylin and eosin stain demonstrating hyperkeratosis and granulomatous dermatitis with necrosis and neutrophils; C) Positive Fite's acid-fast stain (modified acid-fast stain) demonstrating acid-fast bacilli; D) Culture of M. fortuitum on Middlebrook 7H10 agar

Additional cases. We subsequently conducted a review of the medical records of eight patients who had been a part of an isolated outbreak of M. fortuitum infections associated with tattoos in the Charleston, South Carolina area between December 15, 2010, and January 28, 2011. Clinical course, biopsy results, and culture results were reviewed. Once public health officials confirmed an isolated outbreak of tattoo-associated MF infections, these eight cases were linked back to a single tattoo parlor and a single tattoo artist.

This series consisting of eight patients included seven male patients and one female patient. All patients received tattoos from a single tattoo artist in a single tattoo parlor between December 2010 and January 2011. The clinical appearance of their lesions ranged from small dermal papules to edematous and indurated plaques, all of which were confined to black and gray areas of tattoo ink. All cases initially presented between January and February 2011. Six patients were initially treated with topical steroids and antibiotics, while two were initially treated with topical steroids only. Two patients required hospitalization, while the remaining six were managed in an outpatient setting.

Two of six acid-fast bacilli smears were positive for M. fortuitum. Four of six cultures were positive for M. fortuitum. One patient did not undergo a biopsy, and another patient’s sample quantity was not sufficient. All bacterial cultures were negative, except one that was positive for methicillin-resistant Staphylococcus aureus. It is unclear whether this was a concomitant infection or secondary superinfection. Patient characteristics for each case in this series is summarized in Table 1.

TABLE 1.

Patient characteristics

CASE AGE/SEX SYMPTOMS CLINICAL APPEARANCE TIME TO FIRST SX TIME TO DIAGNOSIS/PREVIOUS TREATMENT HISTOPATHOLOGY AFB SMEAR/CULTURE FOR MF TREATMENT
1 M U/A U/A 1–2 weeks Antibiotics + topical steroids U/A −/− Antibacterial
2 33 years/M U/A Erythema and induration with small dermal papules in the black area of the tattoo only 1–2 weeks 6 weeks/TMP-SMX and topical clobetasol Necrotizing granulomatous dermatitis +/+ TMP-SMX and ciprofloxacin ×4 months
3 M U/A U/A 1–2 weeks Antibiotics + topical steroids U/A −/+ U/A
4 M U/A U/A 1 week Topical steroids U/A −/+ Doxycycline BID ×6 months
5 M U/A U/A <1 week Topical steroids U/A QNS Topical steroids
6 F U/A U/A 1–2 weeks Antibiotics + topical steroids U/A -/- Doxycycline BID ×unknown number of months
7 M U/A U/A 3 days Antibiotics + topical steroids U/A No biopsy None
8* 41 years/M Erythema, swelling, painful bleeding, pruritus, malaise, anorexia and nausea Small pustules with overlying crust and desquamation primarily in black-appearing areas of the tattoo; morbilliform rash extending 2–3cm from the areas of black ink 3 days Antibiotics + topical steroids Diffuse suppurative and granulomatous dermatitis with acid fast bacilli +/+ PO Ciprofloxacin + linezolid ×4 months

BID: Twice per day; U/A: Information unavailable; TMP-SMX: Trimethoprim/sulfamethoxazole; QNS: Quantity not sufficient; MF: Mycobacterium fortuitum; Sx: Symptoms; *Index case

DISCUSSION

Nontuberculous mycobacteria are known culprits in tattoo-associated infections. Outbreaks have been reported in which the etiology was gray ink that has been diluted with contaminated water. This contamination has been known to occur at both the level of the manufacturer and the tattoo artist themselves.11,12 Nontuberculous mycobacteria consist of M. chelonae, M. fortuitum, and M. abscessus. In this report, we focus on NTM infections related to M. fortuitum, which has predominantly been implicated in skin and soft tissue, surgical wound, and catheter-related infections by direct inoculation.13 However, it has been reported more rarely in pulmonary, lymphadenitis, disseminated, and prosthetic device infections.14 Although none of the patients in this series were immunosuppressed, the rate of infections associated with NTM is higher in the immunosuppressed population. The nonspecific clinical manifestations are what make M. fortuitum infections a diagnostic and therapeutic challenge. This case series demonstrates how the nonspecific presentation of this infection can contribute to a delay in diagnosis, which unfortunately led to hospitalization of two of the patients discussed here. Because the diagnosis may or may not be confirmed by culture, it must be emphasized that a biopsy is needed in addition to a culture to aid in diagnosis. One should consider M. fortuitum infection when a patient presents with inflammatory signs and symptoms in a tattoo, particularly when the lesions are confined to an area of tattoo with gray ink.

With respect to treatment, there is a variety of antimicrobial susceptibility described in the literature.1517 For infections limited to the skin and soft tissue, current recommendations state that two of the following antimicrobial drugs should be orally administered for a minimum of four months: trimethoprim-sulfamethoxazole, doxycycline, levofloxacin, and clarithromycin or azithromycin. For more extensive skin and soft tissue disease, recommendations consist of parenteral therapy with at least two of the following drugs for two to six weeks: an aminoglycoside (amikacin or tobramycin), cefoxitin, imipenem, and levofloxacin. This should be followed by 6 to 12 months of oral therapy with any of the agents previously mentioned.18

Three notable limitations of our case series include the inability to confirm the gray ink as source of infection due to a failure to obtain a sample; because one case went without an associated biopsy; and that, once cultures were obtained, most patients had already been treated with antimicrobials.

CONCLUSION

We report a series of eight tattoo-associated M. fortuitum infections confined to the areas of gray ink made by a dilution of black ink with tap water, which is the presumed source of infections. Here, we emphasize the lack of pathognomonic features of these infections, the variability in culture and biopsy results, and the importance of obtaining a culture in addition to a biopsy.

REFERENCES

  1. Wagner D, Young LS. Nontuberculous mycobacterial infections: a clinical review. Infection. 2004;32(5):257–270. doi: 10.1007/s15010-004-4001-4. [DOI] [PubMed] [Google Scholar]
  2. Chapman JS. The ecology of the atypical mycobacteria. Arch Environ Health. 1971;22(1):41–46. doi: 10.1080/00039896.1971.10665813. [DOI] [PubMed] [Google Scholar]
  3. Goslee S, Wolinsky E. Water as a source of potentially pathogenic mycobacteria. Am Rev Respir Dis. 1976;113(3):287–292. doi: 10.1164/arrd.1976.113.3.287. [DOI] [PubMed] [Google Scholar]
  4. Gruft H, Falkinham JO, 3rd, Parker BC. Recent experience in the epidemiology of disease caused by atypical mycobacteria. Rev Infect Dis. 1981;3(5):990–996. doi: 10.1093/clinids/3.5.990. [DOI] [PubMed] [Google Scholar]
  5. Wolinsky E, Rynearson TK. Mycobacteria in soil and their relation to disease-associated strains. Am Rev Respir Dis. 1968;97(6):1032–1037. doi: 10.1164/arrd.1968.97.6P1.1032. [DOI] [PubMed] [Google Scholar]
  6. Phillips MS, von Reyn CF. Nosocomial infections due to nontuberculous mycobacteria. Clin Infect Dis. 2001;33(8):1363–1374. doi: 10.1086/323126. [DOI] [PubMed] [Google Scholar]
  7. Griffith DE, Aksamit T, Brown-Elliott BA et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367–416. doi: 10.1164/rccm.200604-571ST. [DOI] [PubMed] [Google Scholar]
  8. Uslan DZ, Kowalski TJ, Wengenack NL, Virk A, Wilson JW. Skin and soft tissue infections due to rapidly growing mycobacteria: comparison of clinical features, treatment, and susceptibility. Arch Dermatol. 2006;142(10):1287–1292. doi: 10.1001/archderm.142.10.1287. [DOI] [PubMed] [Google Scholar]
  9. Huebner RE, Good RC, Tokars J., I Current practices in mycobacteriology: results of a survey of state public health laboratories. J Clin Microbiol. 1993;31(4):771–775. doi: 10.1128/jcm.31.4.771-775.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Nash KA, Brown-Elliott BA, Wallace RJ., Jr A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae. Antimicrob Agents Chemother. 2009;53(4):1367–76. doi: 10.1128/AAC.01275-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Drage LA, Ecker PM, Orenstein R et al. An outbreak of Mycobacterium chelonae infections in tattoos. J Am Acad Dermatol. 2010;62(3):501–506. doi: 10.1016/j.jaad.2009.03.034. [DOI] [PubMed] [Google Scholar]
  12. Kluger N, Muller C, Gral N. Atypical mycobacteria infection following tattooing: review of an outbreak in 8 patients in a French tattoo parlor. Arch Dermatol. 2008;144(7):941–942. doi: 10.1001/archderm.144.7.941. [DOI] [PubMed] [Google Scholar]
  13. Wallace RJ, Jr., Swenson JM, Silcox VA et al. Spectrum of disease due to rapidly growing mycobacteria. Rev Infect Dis. 1983;5(4):657–659. doi: 10.1093/clinids/5.4.657. [DOI] [PubMed] [Google Scholar]
  14. Hoffman PC, Fraser DW, Robicsek F et al. Two outbreaks of sternal wound infection due to organisms of the Mycobacterium fortuitum complex. J Infect Dis. 1981;143(4):533–542. doi: 10.1093/infdis/143.4.533. [DOI] [PubMed] [Google Scholar]
  15. Swenson JM, Wallace RJ, Jr, Silcox VA, Thornsberry C. Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae. Antimicrob Agents Chemother. 1985;28(6):807–811. doi: 10.1128/aac.28.6.807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Brown BA, Wallace RJ, Jr, Onyi GO et al. Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms. Antimicrob Agents Chemother. 1992;36(1):180–184. doi: 10.1128/aac.36.1.180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Wallace RJ, Jr, Brown-Elliott BA, Ward SC et al. Activities of linezolid against rapidly growing mycobacteria. Antimicrob Agents Chemother. 2001;45(3):764–767. doi: 10.1128/AAC.45.3.764-767.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Wallace RJ, Jr, Swenson JM, Silcox VA, Bullen MG. Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonae on the basis of in vitro susceptibilities. J Infect Dis. 1985;152(3):500–514. doi: 10.1093/infdis/152.3.500. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Clinical and Aesthetic Dermatology are provided here courtesy of Matrix Medical Communications

RESOURCES